Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.20
+$0.13 (+0.72%)
Sep 22, 2026, 10:56 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 72.79M | 64.86M | 68.48M | 45.87M | 37.96M | 20.04M | 7.68M | 12.5M | 3.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 126.58M | 12.38M | 379K | 379K |
Cost of Revenue | 3.21M | 2.63M | -1.57M | 2.1M | 1.28M | 885K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 121K | n/a | n/a | n/a |
Gross Profit | 69.58M | 62.23M | 70.05M | 43.77M | 36.68M | 19.16M | 7.68M | 12.5M | 3.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 126.46M | 12.38M | 379K | 379K |
Operating Income | -40M | -34.2M | -62.55M | -57.43M | -69.35M | -83.76M | -96.37M | -89.58M | -74.22M | -79.51M | -77.91M | -56.36M | -49.68M | -46.02M | -42.03M | -35.14M | -37.72M | -36.86M | 95.75M | -20.03M | -22.33M | -27.16M |
Interest Income | 3.75M | 3.56M | 9.6M | 5.27M | 5.95M | 7.18M | 7.11M | 5.44M | 6.28M | 7.26M | 5.55M | 5.35M | 5.19M | 5.08M | 2.99M | 1.78M | 878K | 224K | 91K | 83K | 108K | 120K |
Pretax Income | -49.36M | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M | -27.72M |
Net Income | -49.36M | -42.67M | -68.01M | -60.72M | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M | -27.72M |
Selling & General & Admin | 41.54M | 37.59M | 49.93M | 44.92M | 43.81M | 41.03M | 37.69M | 31.11M | 29.06M | 23.02M | 22.78M | 17.27M | 14.91M | 11.96M | 10.19M | 8.24M | 7.99M | 6.84M | 6.93M | 6.8M | 5.84M | 5.67M |
Research & Development | 68.04M | 58.85M | 78.64M | 56.28M | 62.23M | 61.64M | 65.53M | 70.97M | 48.66M | 56.49M | 55.13M | 39.09M | 34.76M | 34.05M | 31.84M | 26.9M | 29.73M | 30.02M | 23.9M | 25.61M | 16.87M | 21.87M |
Other Expenses | n/a | n/a | 4.03M | n/a | n/a | 247K | 826K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K | -57K |
Operating Expenses | 109.58M | 96.43M | 132.6M | 101.2M | 106.03M | 102.91M | 104.05M | 102.08M | 77.72M | 79.51M | 77.91M | 56.36M | 49.68M | 46.02M | 42.03M | 35.14M | 37.72M | 36.86M | 30.83M | 32.41M | 22.71M | 27.54M |
Interest Expense | 12.68M | 11.85M | 52.7M | 8.28M | 7.86M | 8.05M | 4.81M | 23K | 45K | 55K | 63K | 70K | 35K | 40K | 43K | 1.75M | 695K | 651K | n/a | 649K | 634K | 623K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 112.78M | 99.07M | 131.03M | 103.3M | 107.31M | 103.8M | 104.05M | 102.08M | 77.72M | 79.51M | 77.91M | 56.36M | 49.68M | 46.02M | 42.03M | 35.14M | 37.72M | 36.86M | 30.83M | 32.41M | 22.71M | 27.54M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.99M | 86.62M | 86.62M | 86.62M | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 51.79M | 51.96M | 51.6M | 51.5M |
Shares Outstanding (Diluted) | 88.99M | 86.62M | 86.62M | 86.62M | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 53.18M | 51.96M | 51.6M | 51.5M |
EPS (Basic) | -0.55 | -0.49 | -0.78 | -0.70 | -0.83 | -0.99 | -1.10 | -0.98 | -0.80 | -0.85 | -1 | -0.73 | -0.64 | -0.59 | -0.62 | -0.58 | -0.62 | -0.63 | 1.81 | -0.40 | -0.44 | -0.54 |
EPS (Diluted) | -0.55 | -0.49 | -0.78 | -0.70 | -0.83 | -0.99 | -1.10 | -0.98 | -0.80 | -0.85 | -1 | -0.73 | -0.64 | -0.59 | -0.62 | -0.58 | -0.62 | -0.63 | 1.81 | -0.40 | -0.44 | -0.54 |
EBITDA | -36.69M | -30.82M | -15.31M | -52.43M | -63.93M | -83.76M | -89.36M | -84.1M | -68.02M | -72.34M | -72.41M | -51.07M | -44.58M | -41.08M | -39.15M | -33.65M | -36.87M | -36.51M | 96.32M | -19.98M | -22.27M | -27.08M |
EBIT | -36.69M | -30.83M | -15.31M | -52.43M | -63.99M | -92.9M | -89.36M | -84.1M | -68.02M | -72.35M | -72.41M | -51.08M | -44.58M | -41.09M | -39.15M | -33.66M | -36.88M | -36.52M | 96.2M | -19.99M | -22.28M | -27.1M |
Depreciation & Amortization | n/a | 4K | 3K | 3K | 55K | 9.14M | n/a | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 8K | 11K | 11K | 121K | 8K | 105K | 117K |
Add to Watchlist
Select watchlists to add or remove SNDX